germ cell cancer research hub

Phase II study of dornase alpha and cisplatin in refractory germ cell cancer.

This study is looking at a new way to treat germ cell cancer that hasn't responded to other treatments. It combines a standard chemotherapy drug called cisplatin with a medicine called Pulmozyme. The study wants to see if this combination can stop the cancer from growing for at least 12 weeks.